Replies to post #15961 on Aurinia Pharmaceuticals Inc (AUPH)

[Whalatane]

Well the present reality at the Nephrology dept where my wife works … and sees the occasional LN patient.

Yes we are considering Lupkynis for severe LN … for short periods ( 3-6 mths )
Our challenges
Cost of the drug
Tier rating of the drug plus likely high patient copay
Insurers wanting us to try Benlysta first

And now U know
Good luck
Kiwi

[rosemountbomber]

“ Are you going to refuse a patient population, with marginalized people over represented, access to the best medication available today, for relief from the devastation of a terrible disease?”

You haven’t had much experience with insurance companies I guess. Why don’t you tell us how cheaply a patient can get V for.

[Scott999]

Hey Zzatt. How many scientists do they have. If it works for other biotechs, it MUST work here too right?